Skip to content

Contact +44 (0) 20 7060 7474 email us

Company Information

AstraZeneca PLC - SWOT Analysis

 

Publication Date October 2008
Publisher Datamonitor
Product Type Report
Pages 33
ISBN Number not applicable
Product Code DAT00682

Price

£44.00
approximately: $67 | €49

pdf

Buy Now

Order above formats by FAX

Order by Fax

Summary

Datamonitor's AstraZeneca - SWOT Analysis company profile is the essential source for top-level company data and information. AstraZeneca - SWOT Analysis examines the company's key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy.

AstraZeneca was formed in 1999 by the merger of Swedish-based Astra and UK-based Zeneca Group. The company is the second largest UK pharmaceutical player (behind GlaxoSmithKline). AstraZeneca has a strong presence in the US and retains a significant presence in Sweden as a legacy of Astra. The company is headquartered in London and employs more than 67,000 people worldwide. The company recorded revenues of $29,559 million during the financial year (FY) ended December 2007, an increase of 11.6% over 2006, primarily due the acquisition of MedImmune. The operating profit of the company was $8,094 million during FY2007, a decrease of 1.5% over 2006. The net profit was $5,627 million in FY2007, a decrease of 7.2% over 2006.

Scope of the Report

  • Provides all the crucial information on AstraZeneca required for business and competitor intelligence needs
  • Contains a study of the major internal and external factors affecting AstraZeneca in the form of a SWOT analysis as well as a breakdown and examination of leading product revenue streams of AstraZeneca
  • Data is supplemented with details on AstraZeneca history, key executives, business description, locations and subsidiaries as well as a list of products and services and the latest available statement from AstraZeneca

Reasons to Purchase

  • Support sales activities by understanding your customers' businesses better
  • Qualify prospective partners and suppliers
  • Keep fully up to date on your competitors' business structure, strategy and prospects
  • Obtain the most up to date company information available

This report covers the following industry codes:

SIC Code: 2834

NAICS Code: 325412

Contents

  • This product typically includes the following sections:
  • SWOT COMPANY PROFILE: ASTRAZENECA
    • Key Facts: AstraZeneca
    • Company Overview: AstraZeneca
    • Business Description: AstraZeneca
    • Company History: AstraZeneca
    • Key Employees: AstraZeneca
    • Key Employee Biographies: AstraZeneca
    • Products & Services Listing: AstraZeneca
    • Products & Services Analysis: AstraZeneca
  • SWOT analysis: AstraZeneca
    • Strengths: AstraZeneca
    • Weaknesses: AstraZeneca
    • Opportunities: AstraZeneca
    • Threats: AstraZeneca
  • Company View: AstraZeneca
    • Top Competitors: AstraZeneca
    • Location and Subsidiary: AstraZeneca
    • Head Office: AstraZeneca
    • Other Locations and Subsidiaries: AstraZeneca